» Articles » PMID: 34071133

Transdermal Delivery of Lidocaine-Loaded Elastic Nano-Liposomes with Microneedle Array Pretreatment

Overview
Journal Biomedicines
Date 2021 Jun 2
PMID 34071133
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

This study aimed to improve the transdermal delivery of lidocaine hydrochloride (LidH) using elastic nano-liposomes (ENLs) and microneedle (MN) array pretreatment. LidH-containing ENLs were prepared using soybean phosphatidylcholine and cholesterol, with Span 80 or Tween 80, using a reverse-phase evaporation method. The ENL particle size, stability, and encapsulation efficiency (EE) were characterized and optimized based on the component ratio, pH, and type of surfactant used. In vitro transdermal diffusion study was performed on MN-pretreated mouse skin using Franz diffusion cells. The anesthetic effects of LidH in various formulations after dermal application were evaluated in vivo in rats by measuring the tail withdrawal latency after photothermic stimulation. Stable LidH-loaded Tween 80 or Span 80 ENLs were obtained with particle sizes of 115.8 and 146.6 nm and EEs of 27% and 20%, respectively. The formulations did not exert any cytotoxicity in HaCaT cells. Tween 80 and Span 80 ENL formulations showed enhanced LidH delivery on pretreated mice skin in vitro and prolonged the anesthetic effect in vivo compared to that by LidH application alone. LidH-loaded ENLs applied to MN-pretreated skin can shorten the onset time and prolong the anesthetic effect safely, which merits their further optimization and practical application.

Citing Articles

Editorial to the Special Issue "Theranostic Drug Delivery: Prospects and Problems".

Mozafari M Biomedicines. 2024; 12(7).

PMID: 39062106 PMC: 11274609. DOI: 10.3390/biomedicines12071533.


Comparative study of iontophoresis-assisted transdermal delivery of bupivacaine and lidocaine as anesthetic drugs.

Morarad R, Uerpairojkit K, Chalermkitpanit P, Sirivat A Drug Deliv Transl Res. 2024; 15(2):688-699.

PMID: 38782881 DOI: 10.1007/s13346-024-01627-5.


Lidocaine-Liposomes-A Promising Frontier for Transdermal Pain Management.

Leon M, Mastaleru A, Oancea A, Alexa-Stratulat T, Peptu C, Tamba B J Clin Med. 2024; 13(1).

PMID: 38202278 PMC: 10779996. DOI: 10.3390/jcm13010271.


Current Advances in Lipid Nanosystems Intended for Topical and Transdermal Drug Delivery Applications.

Akombaetwa N, Ilangala A, Thom L, Memvanga P, Witika B, Buya A Pharmaceutics. 2023; 15(2).

PMID: 36839978 PMC: 9967415. DOI: 10.3390/pharmaceutics15020656.


Enhancing Intradermal Delivery of Lidocaine by Dissolving Microneedles: Comparison between Hyaluronic Acid and Poly(Vinyl Pyrrolidone) Backbone Polymers.

Ramadon D, Sutrisna L, Harahap Y, Putri K, Ulayya F, Hartrianti P Pharmaceutics. 2023; 15(1).

PMID: 36678916 PMC: 9864429. DOI: 10.3390/pharmaceutics15010289.


References
1.
Nayak A, Babla H, Han T, Das D . Lidocaine carboxymethylcellulose with gelatine co-polymer hydrogel delivery by combined microneedle and ultrasound. Drug Deliv. 2014; 23(2):658-69. DOI: 10.3109/10717544.2014.935985. View

2.
Duarah S, Sharma M, Wen J . Recent advances in microneedle-based drug delivery: Special emphasis on its use in paediatric population. Eur J Pharm Biopharm. 2019; 136:48-69. DOI: 10.1016/j.ejpb.2019.01.005. View

3.
Yang H, Kang G, Jang M, Um D, Shin J, Kim H . Development of Lidocaine-Loaded Dissolving Microneedle for Rapid and Efficient Local Anesthesia. Pharmaceutics. 2020; 12(11). PMC: 7695299. DOI: 10.3390/pharmaceutics12111067. View

4.
Donnelly R, Raghu Raj Singh T, Woolfson A . Microneedle-based drug delivery systems: microfabrication, drug delivery, and safety. Drug Deliv. 2010; 17(4):187-207. PMC: 2906704. DOI: 10.3109/10717541003667798. View

5.
Teaima M, El Mohamady A, El-Nabarawi M, Mohamed A . Formulation and evaluation of niosomal vesicles containing ondansetron HCL for trans-mucosal nasal drug delivery. Drug Dev Ind Pharm. 2020; 46(5):751-761. DOI: 10.1080/03639045.2020.1753061. View